Free Trial

Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume

Galera Therapeutics logo
$0.02 0.00 (-8.88%)
As of 06/4/2025 03:39 PM Eastern

Galera Therapeutics Short Interest Data

Galera Therapeutics (GRTX) has a short interest of 7,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 103,159 shares to cover all short positions.

Current Short Interest
7,400 shares
Previous Short Interest
7,400 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$177.60
Short Interest Ratio
0.1 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
75,462,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
64,285 shares
Average Trading Volume
103,159 shares
Today's Volume Vs. Average
62%
Short Selling Galera Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GRTX Short Interest Over Time

GRTX Days to Cover Over Time

GRTX Percentage of Float Shorted Over Time

Galera Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20257,400 shares $177.60 No ChangeN/A0.1 $0.02
4/30/20257,400 shares $163.54 No ChangeN/A0.1 $0.02
4/15/20257,400 shares $199.80 No ChangeN/A0 $0.03
3/14/20257,400 shares $251.60 No ChangeN/A0.1 $0.03
2/28/20257,400 shares $283.42 -3.9%N/A0.1 $0.04
2/14/20257,700 shares $323.40 -79.0%N/A0 $0.04
1/31/202536,600 shares $1,559.16 -3.2%N/A0.4 $0.04
1/15/202537,800 shares $1,742.58 +410.8%N/A0 $0.05
5/31/20241,910,000 shares $410,841.00 -9.9%5.5%1.1 $0.22
5/15/20242,120,000 shares $402,800.00 -24.0%6.1%1 $0.19
4/30/20242,790,000 shares $519,777.00 +4.9%7.3%1.4 $0.19
4/15/20242,660,000 shares $406,714.00 +50.3%6.5%1.4 $0.15
3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14
3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21
2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24
2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18
1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18
1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22
12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15
12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14
11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14
11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14
10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10
10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19
9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18
9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19
8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21
8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27
7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46
7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75
6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12
6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39
5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07
5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18
10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45
10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55
9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74
9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87
8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34
8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46
The DOJ Just Paved the Way for Account Seizures (Ad)

Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.

Get your free guide now by clicking here >>
7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16
7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20
6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30
6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48
5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60
5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51
4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69
4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13
3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38
3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10
2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24
2/15/2022297,000 shares $694,980.00 +93.7%1.7%0 $2.34
1/31/2022153,300 shares $420,042.00 -73.6%1.4%0 $2.74
1/15/2022580,700 shares $2.00 million -71.0%N/A0 $3.44
12/31/20212,000,000 shares $9.18 million +226.7%18.0%0.2 $4.59
12/15/2021612,100 shares $1.78 million -17.2%5.5%0.1 $2.90
11/30/2021739,100 shares $975,612.00 +14.6%7.1%0.2 $1.32
11/15/2021645,000 shares $1.08 million -57.6%6.2%0.2 $1.68
10/29/20211,520,000 shares $2.84 million +814.0%15.2%0.6 $1.87
10/15/2021166,300 shares $1.30 million +8.5%1.7%0.2 $7.81
9/30/2021153,300 shares $1.24 million -3.1%1.5%2.2 $8.10
9/15/2021158,200 shares $1.14 million -11.9%1.5%1.7 $7.18
8/31/2021179,600 shares $1.61 million -4.5%1.7%1.6 $8.96
8/13/2021188,100 shares $1.56 million -16.1%1.8%1.5 $8.30
7/30/2021224,200 shares $1.88 million -15.6%2.1%1.5 $8.38
7/15/2021265,600 shares $2.48 million -3.6%2.5%0.4 $9.34
6/30/2021275,500 shares $2.71 million -43.9%2.6%0.4 $9.83
6/15/2021490,900 shares $4.40 million +0.9%4.7%0.8 $8.96
5/28/2021486,600 shares $4.17 million -1.5%4.6%0.8 $8.57
5/14/2021494,000 shares $3.52 million +51.2%4.8%0.9 $7.12
4/30/2021326,700 shares $2.65 million +103.4%3.4%0.6 $8.12
4/15/2021160,600 shares $1.21 million +4.8%N/A0 $7.52
3/31/2021153,200 shares $1.28 million +6.0%1.6%2.3 $8.35
3/15/2021144,500 shares $1.59 million -2.0%1.5%2.2 $11.00
2/26/2021147,500 shares $1.55 million +13.5%1.5%2.1 $10.48
2/12/2021130,000 shares $1.54 million +12.9%1.3%1.9 $11.84
1/29/2021115,200 shares $1.22 million +25.6%1.4%1.7 $10.63
1/15/202191,700 shares $917,917.00 -18.7%1.1%1 $10.01
12/31/2020112,800 shares $1.22 million -5.7%1.4%1.5 $10.79
12/15/2020119,600 shares $1.29 million -1.0%1.4%1.3 $10.80
11/30/2020120,800 shares $1.35 million -10.8%1.5%1.5 $11.21
11/15/2020135,400 shares $1.38 million -4.1%1.6%1.8 $10.20
10/30/2020141,200 shares $1.24 million +63.8%1.7%2 $8.78
10/15/202086,200 shares $1.08 million -6.6%0.9%1.4 $12.50
9/30/202092,300 shares $834,392.00 -11.0%1.0%2.2 $9.04
9/15/2020103,700 shares $852,414.00 -8.2%1.1%2.5 $8.22
8/31/2020112,900 shares $881,749.00 -2.0%1.2%1.7 $7.81
8/14/2020115,200 shares $899,712.00 -1.5%1.2%1.6 $7.81
7/31/2020116,900 shares $813,624.00 -7.8%1.2%1.6 $6.96
7/15/2020126,800 shares $997,916.00 +4.4%1.3%1.8 $7.87
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
6/30/2020121,500 shares $982,935.00 -11.5%1.3%1.8 $8.09
6/15/2020137,300 shares $1.20 million +981.1%1.6%3 $8.72

GRTX Short Interest - Frequently Asked Questions

What is Galera Therapeutics' current short interest?

Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 7,400 shares of GRTX short. Learn More on Galera Therapeutics' current short interest.

How does Galera Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galera Therapeutics: Traws Pharma, Inc. (1.65%), Mainz Biomed (2.66%), Avalon GloboCare Corp. (3.30%), PharmaCyte Biotech, Inc. (0.06%), Omega Therapeutics, Inc. (26.99%), Citius Pharmaceuticals, Inc. (6.22%), Cardio Diagnostics Holdings, Inc. (3.48%), Pasithea Therapeutics Corp. (8.00%), NLS Pharmaceutics Ltd. (1.74%), Sunshine Biopharma, Inc. (6.40%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Galera Therapeutics stock?

Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. GRTX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Galera Therapeutics?

A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further.

How often is Galera Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:GRTX) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners